Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-04-06 Purchase | 2023-04-10 5:26 pm | GT Biopharma Inc. | GTBP | Ohri Manu CFO & Secretary | 50,000 | $0.5 | $25,000 | 150,000 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-02-14 Option Award | 2024-02-20 4:32 pm | N/A N/A | Axil Brands Inc. | AXIL | Ohri Manu Director | 5,000 | $0 | 15,001 (Direct) | View |
Ownership | 2024-02-20 4:30 pm | N/A N/A | Axil Brands Inc. | AXIL | Ohri Manu Director | 0 | $0 | 10,001 (Direct) | View |
2023-08-11 Option Award | 2023-08-15 7:26 pm | N/A N/A | GT Biopharma Inc. | GTBP | Ohri Manu CFO & Secretary | 200,000 | $0.287 | 750,000 (Direct) | View |
2023-08-11 Other | 2023-08-15 7:26 pm | N/A N/A | GT Biopharma Inc. | GTBP | Ohri Manu CFO & Secretary | 200,000 | $0.287 | 750,000 (Direct) | View |
2023-01-27 Option Award | 2023-02-01 06:02 am | N/A 2033-01-26 | GT Biopharma Inc. | GTBP | Ohri Manu Chief Financial Officer | 500,000 | $0 | 500,000 (Direct) | View |
2022-07-15 Option Award | 2022-07-19 9:44 pm | N/A 2032-07-14 | GT Biopharma Inc. | GTBP | Ohri Manu CFO & Secretary | 300,000 | $0 | 500,000 (Direct) | View |
2022-07-15 Other | 2022-07-19 9:44 pm | N/A N/A | GT Biopharma Inc. | GTBP | Ohri Manu CFO & Secretary | 100,000 | $0 | 500,000 (Direct) | View |